Blondel M - Search Results

1

Synthesis of conjugates of 6-aminophenanthridine and guanabenz, two structurally unrelated prion inhibitors, for the determination of their cellular targets by affinity chromatography.

Gug F, Oumata N, Tribouillard-Tanvier D, Voisset C, Desban N, Bach S, Blondel M, Galons H. Gug F, et al. Among authors: blondel m. Bioconjug Chem. 2010 Feb 17;21(2):279-88. doi: 10.1021/bc900314n. Bioconjug Chem. 2010. PMID: 20092293

2

Isolation of drugs active against mammalian prions using a yeast-based screening assay.

Bach S, Talarek N, Andrieu T, Vierfond JM, Mettey Y, Galons H, Dormont D, Meijer L, Cullin C, Blondel M. Bach S, et al. Among authors: blondel m. Nat Biotechnol. 2003 Sep;21(9):1075-81. doi: 10.1038/nbt855. Epub 2003 Aug 10. Nat Biotechnol. 2003. PMID: 12910243

3

A yeast-based assay to isolate drugs active against mammalian prions.

Bach S, Tribouillard D, Talarek N, Desban N, Gug F, Galons H, Blondel M. Bach S, et al. Among authors: blondel m. Methods. 2006 May;39(1):72-7. doi: 10.1016/j.ymeth.2006.04.005. Methods. 2006. PMID: 16750390

4

Using budding yeast to screen for anti-prion drugs.

Tribouillard D, Bach S, Gug F, Desban N, Beringue V, Andrieu T, Dormont D, Galons H, Laude H, Vilette D, Blondel M. Tribouillard D, et al. Among authors: blondel m. Biotechnol J. 2006 Jan;1(1):58-67. doi: 10.1002/biot.200500001. Biotechnol J. 2006. PMID: 16892225

5

Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography.

Guiffant D, Tribouillard D, Gug F, Galons H, Meijer L, Blondel M, Bach S. Guiffant D, et al. Among authors: blondel m. Biotechnol J. 2007 Jan;2(1):68-75. doi: 10.1002/biot.200600223. Biotechnol J. 2007. PMID: 17225251

6

Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions.

Tribouillard-Tanvier D, Béringue V, Desban N, Gug F, Bach S, Voisset C, Galons H, Laude H, Vilette D, Blondel M. Tribouillard-Tanvier D, et al. Among authors: blondel m. PLoS One. 2008 Apr 23;3(4):e1981. doi: 10.1371/journal.pone.0001981. PLoS One. 2008. PMID: 18431471 Free PMC article.

7

Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugs.

Tribouillard-Tanvier D, Dos Reis S, Gug F, Voisset C, Béringue V, Sabate R, Kikovska E, Talarek N, Bach S, Huang C, Desban N, Saupe SJ, Supattapone S, Thuret JY, Chédin S, Vilette D, Galons H, Sanyal S, Blondel M. Tribouillard-Tanvier D, et al. Among authors: blondel m. PLoS One. 2008 May 14;3(5):e2174. doi: 10.1371/journal.pone.0002174. PLoS One. 2008. PMID: 18478094 Free PMC article.

8

Tools for the study of ribosome-borne protein folding activity.

Voisset C, Thuret JY, Tribouillard-Tanvier D, Saupe SJ, Blondel M. Voisset C, et al. Among authors: blondel m. Biotechnol J. 2008 Aug;3(8):1033-40. doi: 10.1002/biot.200800134. Biotechnol J. 2008. PMID: 18683165 Review.

9

Antiprion drugs as chemical tools to uncover mechanisms of prion propagation.

Tribouillard D, Gug F, Galons H, Bach S, Saupe SJ, Blondel M. Tribouillard D, et al. Among authors: blondel m. Prion. 2007 Jan-Mar;1(1):48-52. doi: 10.4161/pri.1.1.4053. Epub 2007 Jan 20. Prion. 2007. PMID: 19164923 Free PMC article. Review.

10

Procedure for identification and characterization of drugs efficient against mammalian prion: from a yeast-based antiprion drug screening assay to in vivo mouse models.

Voisset C, Saupe SJ, Galons H, Blondel M. Voisset C, et al. Among authors: blondel m. Infect Disord Drug Targets. 2009 Feb;9(1):31-9. doi: 10.2174/1871526510909010031. Infect Disord Drug Targets. 2009. PMID: 19200013

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page